​

• State First in DM entrance Examination

• Best orator award in the year 2013 –TYSA

• Golden AIM award – “Innovative Healthcare Leadership Award-Gastroenterologist” – Nov 2020

• Clinical Observership  &  Hands-on Training in Third Space  Endoscopy  ,West China Hospital, Chengdu – 2019

• Postgraduate Gastroenterology Certificate

         American College  of Gastroenterology  - 2019

• Digestive Disease SE 8- Inflammatory Bowel Disease

         American Gastroenterology Association – 2019

• Post Graduate Excellence Program & CME - Acid Peptic Disorders & IBS, Hepatobiliary Disorders, Colorectal Disorders Boston University – 2020

​

1. Nanda RA and Mohammed A , Mucosal healing after high dose pantoprazole in acute corrosive injury of esophagus -J Med Allied Sci. 2020; 10(2)
2. Renuka Prasad, K., Chettri, P., Rajesh, N.A. et al. Assessment of the risk of acute kidney injury associated with the use of pantoprazole and esomeprazole. Drugs Ther Perspect 34, 223–230 (2018). https://doi.org/10.1007/s40267-018-0503-5
3. Kumaran SV, Amarnath Rajesh N, Ali M, Pugazhendhi T.(2020).Comparison of Fatty Meal, Drotaverine and Hyoscine for Duodenal Anti-motility and Cannulation During ERCPA Randomised Controlled Trial, 14(11), OC14 OC18. https://www.doi.org/10.7860/JCDR/2020/45986/14222
4. NANDA, Rajesh A.; GEORGE, Melvin. Prevalence of duodenal ulcer and associated Helicobacter pylori infection in chronic liver disease. International Journal of Research in Medical Sciences, [S.l.], v. 8, n. 12, p. 4442-4446, Nov. 2020
5. Comparative study of Clarithromycin versus Levofloxacin based triple drug therapy as first line eradication for H. pylori infection.(under review)
6. Safety And Efficacy Of Saroglitazar In Non-alcoholic Fatty Liver Patients With Diabetic Dyslipidemia – A Prospective, Observational  Study (under review)
Rajesh A Nanda, Oral presentation at Asia Pacific Digestive Week 2019 (International  Conference) -Risk of Renal injury with Proton pump inhibitor